TOP2A and cancer: Furthermore, S. Zeng et al. found that TOP2A was highly overexpressed in BCa, especially in high-grade and advanced-stage tumors, and its overexpression was highly connected with worse cancer-specific, progression-free, and recurrence-free survival [217].